Newsfeeds Archive - Page 2 of 8

3 minute read

Editas Medicine To Present Clinical Data From The RUBY And EdiTHAL Trials Of EDIT-301 At The ASH 2023 Annual Meeting And In A Company-Sponsored Webinar

November 2, 9:25 AM

Company to host a webinar to discuss EDIT-301 clinical data on Monday, December 11, at 1:00 p.m. ETDr. Rabi Hanna from Cleveland Clinic Children's to present EDIT-301 clinical data at ASH on Monday, December 11CAMBRIDGE,

EDIT

14 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 24, 2023

By Benzinga Insights

October 24, 11:00 AM

Upgrades For Martin Marietta Materials Inc (NYSE:MLM), Seaport Global upgraded the previous rating of Neutral to Buy. For…

ABNB

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 18, 2023

By Benzinga Insights

October 18, 11:00 AM

Upgrades According to National Bank Financial Inc, the prior rating for Brookfield Infrastructure Partners LP (NYSE:BIP) was changed…

ALB

2 minute read

Analyst Ratings

Analyst Ratings for Editas Medicine

By Benzinga Insights

October 18, 9:00 AM

Analysts have provided the following ratings for Editas Medicine (NASDAQ:EDIT) within the last quarter: Bullish Somewhat Bullish Indifferent…

EDIT

1 minute read

Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst

By Vandana Singh

October 17, 2:35 PM

Cantor Fitzgerald has downgraded Editas Medicine Inc (NASDAQ: EDIT) to Neutral from Overw

BLUE

20 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 17, 2023

By Benzinga Insights

October 17, 11:00 AM

Upgrades According to Wolfe Research, the prior rating for TC Energy Corp (NYSE:TRP) was changed from Underperform to…

ACA

1 minute read

NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

By Lisa Levin

October 17, 6:25 AM

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

AMAM

3 minute read

Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

September 29, 2:09 PM

Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share.

ADD

1 minute read

Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock

By Vandana Singh

September 29, 1:40 PM

Stifel has upgraded Editas Medicine Inc (NASDAQ: EDIT), saying the company's sickle cell disease candidate, EDIT-301's progress, has received minimal credit from investors.

CRSP